MedPath

WALVE BIOTECH PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

TGA:8

Drug Approvals

Revefore Kids Lysine Plus Chewable Tablets (496990)

Product Name
Revefore Kids Lysine Plus Chewable Tablets
Approval Date
Jul 4, 2025
TGA

Revefore Beauty Bloom Botanical Bright (496986)

Product Name
Revefore Beauty Bloom Botanical Bright
Approval Date
Jul 4, 2025
TGA

ANG-V Pro Women's Multivitamin (483566)

Product Name
ANG-V Pro Women's Multivitamin
Approval Date
Mar 21, 2025
TGA

ANG-V Pro Men's Multivitamin (483356)

Product Name
ANG-V Pro Men's Multivitamin
Approval Date
Mar 20, 2025
TGA

Revefore NMN 18000 (466306)

Product Name
Revefore NMN 18000
Approval Date
Oct 29, 2024
TGA

Revefore Liver Tonic 35000mg Vegan Hard-Shell Capsules (462079)

Product Name
Revefore Liver Tonic 35000mg Vegan Hard-Shell Capsules
Approval Date
Sep 9, 2024
TGA

Revefore CoQ10 150mg with Omega-3 Softgel Capsules (451148)

Product Name
Revefore CoQ10 150mg with Omega-3 Softgel Capsules
Approval Date
Jun 5, 2024
TGA

Shark Cartilage With Calcium (434531)

Product Name
Shark Cartilage With Calcium
Approval Date
Jan 17, 2024
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.